Literature DB >> 11973028

MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging.

Deming Wang1, Jonathan B Chalk, Stephen E Rose, Greig de Zubicaray, Gary Cowin, Graham J Galloway, Daniel Barnes, Donna Spooner, David M Doddrell, James Semple.   

Abstract

We present global and regional rates of brain atrophy measured on serially acquired T1-weighted brain MR images for a group of Alzheimer's disease (AD) patients and age-matched normal control (NC) subjects using the analysis procedure described in Part I. Three rates of brain atrophy: the rate of atrophy in the cerebrum, the rate of lateral ventricular enlargement and the rate of atrophy in the region of temporal lobes, were evaluated for 14 AD patients and 14 age-matched NC subjects. All three rates showed significant differences between the two groups. However, the greatest separation of the two groups was obtained when the regional rates were combined. This application has demonstrated that rates of brain atrophy, especially in specific regions of the brain, based on MR images can provide sensitive measures for evaluating the progression of AD. These measures will be useful for the evaluation of therapeutic effects of novel therapies for AD.

Entities:  

Mesh:

Year:  2002        PMID: 11973028     DOI: 10.1016/s0730-725x(02)00472-1

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  20 in total

1.  Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

Authors:  J M Schott; C Frost; J L Whitwell; D G Macmanus; R G Boyes; M N Rossor; N C Fox
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils.

Authors:  Richard G Boyes; Jeff L Gunter; Chris Frost; Andrew L Janke; Thomas Yeatman; Derek L G Hill; Matt A Bernstein; Paul M Thompson; Michael W Weiner; Norbert Schuff; Gene E Alexander; Ronald J Killiany; Charles DeCarli; Clifford R Jack; Nick C Fox
Journal:  Neuroimage       Date:  2007-10-30       Impact factor: 6.556

Review 3.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

Review 4.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

Review 5.  Issues for clinical drug development in neurodegenerative diseases.

Authors:  Michel Dib
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults.

Authors:  Christos Sidiropoulos; Kourosh Jafari-Khouzani; Hamid Soltanian-Zadeh; Panayiotis Mitsias; Panagiotis Alexopoulos; Tanja Richter-Schmidinger; Martin Reichel; Piotr Lewczuk; Arnd Doerfler; Johannes Kornhuber
Journal:  Acta Neuropsychiatr       Date:  2011-06       Impact factor: 3.403

7.  Mapping ventricular expansion onto cortical gray matter in older adults.

Authors:  Sarah K Madsen; Boris A Gutman; Shantanu H Joshi; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

8.  Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease.

Authors:  Jennifer L Whitwell; Clifford R Jack; V Shane Pankratz; Joseph E Parisi; David S Knopman; Bradley F Boeve; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage       Date:  2007-10-10       Impact factor: 6.556

9.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

10.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.